François Lontrade is an Executive Director at Laboratoires Théa. He currently holds the Equity Investments Director and CFO position for TOI. He is also M&A Director for Laboratoires Thea and Managing Director of Sincler. He has joined Théa in 2004 as Group CFO for 11 years. Then he has been Group Industrial, Purchasing and Supply Chain Director. Before joining Théa, he was a Director in Management Consulting at Management Consulting Group and started his career in the automotive industry as a controller at Valeo. François Lontrade graduated as an engineer from ESPCI Paris and holds a Master degree in Finance from ESSEC Business School Paris. He is a Board Member at Ripple Therapeutics (Toronto, Canada) and Coave Therapeutics (Paris, France).